Hence, these data confirmed the findings by Dr. von Herrath et al. that GAD-alum alone does not protect mice from diabetes [14], and that reducing the responding islet-specific T cells with anti-IL-7Rα mAbs (Fig 1C) was not sufficient to alter the outcome of this vaccination strategy. The gene discussed is GAD1; the disease is diabetes mellitus.